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Background: Sleep disturbances are common in rheumatoid arthritis (RA) patients and con-
tribute to loss of life quality.
Objective: To study associations of sleep quality with pain, depression and disease activity
in  RA.
Methods: This is a transversal observational study of 112 RA patients submitted to mea-
surement of DAS-28, Epworth scale for daily sleepiness, index of sleep quality by Pittsburg
index, risk of sleep apnea by the Berlin questionnaire and degree of depression by the
CES-D (Center for Epidemiologic Studies Depression scale) questionnaire. We also collected
epidemiological, clinical, serological and treatment data.
Results: Only 18.5% of RA patients had sleep of good quality. In univariate analysis a bad
sleep measured by Pittsburg index was associated with daily doses of prednisone (p = 0.03),
DAS-28 (p = 0.01), CES-D (p = 0.0005) and showed a tendency to be associated with Berlin sleep
apnea  questionnaire (p = 0.06). In multivariate analysis only depression (p = 0.008) and Berlin
sleep apnea questionnaire (p = 0.004) kept this association.
Conclusions: Most of RA patients do not have a good sleep quality. Depression and risk of
sleep apnea are independently associated with sleep impairment.
© 2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Artrite  reumatoide  e  qualidade  do  sono
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Antecedentes: Os distúrbios do sono são comuns em pacientes com artrite reumatoide (AR)
e  contribuem para a perda da qualidade de vida.
Objetivo: Estudar as associac¸ões entre a qualidade do sono e a dor, depressão e atividade da
doenc¸a  na AR.Please cite this article in press as: Goes AC, et al. Rheumatoid arthritis and sleep quality. Rev Bras Reumatol. 2016.
http://dx.doi.org/10.1016/j.rbre.2016.07.011
epressão
or
Métodos: Estudo observacional transversal com 112 pacientes com AR submetidos à
avaliac¸ão do DAS-28, escala de Epworth para sonolência diurna, qualidade do sono pelo
índice  de Pittsburg, risco de apneia do sono pelo questionário de Berlim e grau de depressão
pelo questionário CES-D (Center for Epidemiologic Studies Depression). Também foram coletados
dados epidemiológicos, clínicos, sorológicos e de tratamento.
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icenses/by-nc-nd/4.0/).
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Resultados: Apenas 18,5% dos pacientes com AR tinham uma boa qualidade do sono. Na
análise univariada, um sono ruim medido pelo índice de Pittsburg esteve associado à dose
diária de prednisona (p = 0,03), DAS-28 (p = 0,01), CES-D (p = 0,0005) e mostrou uma  tendência
a  estar associado à apneia do sono pelo questionário de Berlim (p = 0,06). Na análise mul-
tivariada, somente a depressão (p = 0,008) e a apneia do sono pelo questionário de Berlim
(p  = 0,004) mantiveram essa associac¸ão.
Conclusões: A maior parte dos pacientes com AR não tem uma boa qualidade de sono. A
depressão e o risco de apneia do sono estão independentemente associados ao comprome-
timento do sono.
© 2016 Elsevier Editora Ltda. Este e´ um artigo Open Access sob uma licenc¸a CCIntroduction
Patients’ well-being is a major concern in rheumatoid arthritis
(RA). Patients with RA suffer from a variety of symptoms such
as joint pain and swelling, stiffness, fatigue and functional
disability, that impair their quality of life. Sleep disturbances
are also common in this population and contribute to the
problem.1 Several studies have found sleep fragmentation, low
sleep efﬁciency, frequent awakenings and poor sleep quality
in this group of patients.1–3
Nicassio et al.4 consider pain and sleep disturbance to
be closely linked. However it is difﬁcult to know which one
is the primary problem. Although the inﬂammatory process
brought by RA activity is responsible for pain initiation, inves-
tigators have found that, in some patients, pain intensity
may be out of proportion to the severity of inﬂammation.5
It is believed that this is due to central nervous system pain
ampliﬁcation, mainly due to diminished conditioned pain
modulation.5 Psychological distress, most notably depres-
sion and/or anxiety is another variable implicated in this
relationship.1,4
To look further into this issue, we have studied a sample
of RA Brazilian patients in order to clarify the associations of
sleep quality with pain, depression and disease activity.
Methods
After approval of the local Committee of Ethics in Research
and signed consent from patients we studied 112 RA patients
from a single University Center. This was a convenience sam-
ple of patients that came for regular consultations in the
period of one year and accepted to participate in the study.
All subjects had to fulﬁll at least four 1987 ACR criteria for RA
classiﬁcation.6 We  excluded patients with age under 18 years,
with disease beginning before 16 years, pregnant women,
those with uncontrolled thyroid disease or with other chronic
inﬂammatory condition and those using sleep inductor med-
ications. We  collected demographic, clinical and serological
data, values of hemoglobin, ESR (erythrocyte sedimentation
rate), CRP (C reactive protein) and DAS-28. Diurnal somnolencePlease cite this article in press as: Goes AC, et al. Rheuma
http://dx.doi.org/10.1016/j.rbre.2016.07.011
was evaluated by the Epworth scale,7 the index of sleep qual-
ity by the Pittsburg index,8 and the risk of sleep apnea by the
Berlin questionnaire.9 Depression was measured by the CES-D
Questionnaire or Center for Epidemiologic Studies DepressionBY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
scale.10 All the applied instruments were translated and vali-
dated for the Portuguese language. Fatigue and global health
were measured by a visual analogic scale from 0 (none) to 100
(maximal).
Patients were divided in those with good and poor sleep
quality according to the Pittsburg index (equal or lower than
5 = good sleep; >5 = sleep disorder) and these two  samples
were compared. For this comparison we  used Fisher and
chi-squared tests for nominal data and Mann Whitney and
unpaired t test for numerical data. Associations with p ≤ 0.10
were studied through linear regression to test the variables
independence. Signiﬁcance adopted was of 5%.
Results
Overview  of  studied  sample  and  prevalence  of  sleep
disturbances
In the 112 RA patients, 83.1% were female, with age ran-
ging from 21 to 77 years (mean 55.4 ± 10.9 years) and disease
duration from 9 months to 53 years (median 11 years; IQR
or interquartile rate = 5–18). Auto declared Afro descendants
were 19.6%; 1.7% Asiatic descendants and 78.5% Caucasians.
Tobacco exposure occurred in 39.2% while 60.3% never
smoked. The body mass index varied from 17.3 to 46.4 kg/m2
(median of 27.5; IQR = 24.3–31.5 kg/m2). Rheumatoid factor (RF)
was present in 59.6%; anti-CCP in 47.6%; ANA (antinuclear
antibody) in 34.9%.
Treatment proﬁle at the time of study showed that pred-
nisone was used in 71.4% (doses from 5.0 to 60.0 mg;  median
5.0; IQR = 5.0–10.0); methotrexate in 73.2%, antimalarial in
21.4%, leﬂunomide in 43.7%, anti TNF-alpha in 5.3% and abat-
acept in 2.6%.
Table 1 shows the results of laboratory tests and applied
questionnaires.
Comparison  study  of  RA  patients  with  good  and  poor  sleep
quality
Studying the comparison of patients with and without good
sleep quality according to the Pittsburg index we obtained the
results in Table 2.toid arthritis and sleep quality. Rev Bras Reumatol. 2016.
The result of DAS 28 (ESR) in the samples with and without
good sleep quality is seen in Fig. 1.
The comparison of VAS fatigue, Epworth sleepiness scale
and Berlin sleep apnea screening questionnaire showed
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Table 1 – Laboratory and questionnaires results in 112 rheumatoid arthritis patients.
Studied variable Values
Erythrocyte sedimentation rate (mm/h) 1–103 (median 35.0; IQR = 19.7–58.0)
C reactive protein (mg/dL) 0.15–80.0 (median 10.9; IQR = 5.0–20.7)
Hemoglobin 10.9–16.9 (mean 13.3 ± 1.2)
VAS global 0–100 (median 30.0; IQR = 30.0–60.0)
VAS pain 0–100  (median 60.0; IQR 30.0–80.0)
VAS fatigue 0–100  (median 50.0; IQR 0–80.0)
Body mass index (kg/m2) 17.3–46.4 (median 27.5; IQR = 24.3–31.5)
• Underweight (<18.5) – 4/112 = 3.5%
• Normal (18.6–24.9) – 29/112 = 25.8%
• Overweight (25–29.9) – 43/112 = 38.3%
• Obesity (≥30) – 36/112 = 32.1%
DAS-28 (ESR) 0.28–7.38 (mean 3.75 ± 1.28)
Epworth sleepiness scale 0–24.0 (median 6.0; IQR 3.0–12.0)
• Normal = 79/112 (70.5%)
• Pathological somnolence = 12/112 (10.7%)
• Signiﬁcant somnolence = 21/112 (18.7%)
Berlin or sleep apnea screening questionnaire 0–3.0 (median 1.0; IQR = 3.0–2.0)
• Low risk of sleep apnea = 58/112 (51.7%)
• High risk of sleep apnea = 54/112 (48.2%)
Pittsburg sleep quality index 1–18 (median 9.0; IQR 5.0–18.0)
• Sleep of good quality = 21/112 (18.5%)
• Sleep disturbance = 47/112 (41.9%)
• Bad sleep = 44/112 (39.2%)
Center for Epidemiologic Studies Depression Scale (CES-D) 0–60 (median 13.0; IQR = 6.0–22.0)
• Normal – 63/112 = 56.1%
• Depressive – 49/112 = 43.7%
VAS, visual analogic scale; DAS-28, Disease Activity Score Calculator.
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pespectively p = 0.04, p = 0.84 and p = 0.06 (Mann Whitney). The
esult of association of Pittsburg index with depression (CES-D)
s in Fig. 2.
In a multiple regression study that included daily doses of
rednisone, VAS fatigue, number of tender joints, results of
erlin sleep apnea screening questionnaire, Depression CES-D
uestionnaire and number of painful joints (from DAS 28), we
ound that the Pittsburg index associated independently withPlease cite this article in press as: Goes AC, et al. Rheuma
http://dx.doi.org/10.1016/j.rbre.2016.07.011
ES-D depression questionnaire (p = 0.008) and Berlin apnea
creening questionnaire (p = 0.004).
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ig. 1 – Comparison of DAS-28 (ESR) according to sleep
uality measured by Pittsburg index (p = 0.01; Mann
hitney). Comparison of ESR with p = 0.12; global VAS with
 = 0.43; number of swollen joints with p = 0.31; number of
ainful joints with p = 0.005.Discussion
One of the most striking ﬁndings of the present study is that
less than 20% of RA patients have a sleep of good quality. This
must be taken into account in daily practice if one intends to
improve patients’ quality of life. This high prevalence of sleep
disorder has already been noted by others.1–4
In this study, univariate analysis disclosed association of
poor sleep with DAS 28, daily dose of prednisone, fatigue,
depression and risk of sleep apnea. Sariyildiz et al.1 and Sontoid arthritis and sleep quality. Rev Bras Reumatol. 2016.
et al.11 have also found association of disease activity with
poor sleep quality. Some studies have documented qualita-
tive alterations and rupture in sleep continuity in relationship
Pittsburg < 5 Pittsburg= and > 5
0
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Fig. 2 – Association study of depression measured by CES-D
and sleep quality measured by Pittsburg index (p = 0.0005).
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Table 2 – Comparison of demographic, laboratorial, serological and treatment data in rheumatoid arthritis patients
according to sleep quality measured by Pittsburg index (good sleep ≤ 5; sleep disorder > 5).
Pittsburg index ≤ 5
n = 21
Pittsburg index > 5
n = 91
p
Gender (male/female) 5/16 13/78 0.32a
Tabagism (smokers/not smokers) 5.2% 14.2% 1.00a
Ethnic background
(Afrodescendants/Caucasians)
2/18  20/71 0.35a
Mean age (years) 58.4 ± 2.2 54.7± 10.6 0.15b
Mean age at diagnosis (years) 45.0 ± 15.6 42.5 ± 11.56 0.42b
Median body mass index (kg/m2) 26.7
(IQR = 22.3–28.6)
27.6
(IQR  = 24.7–31.59)
0.25c
Positive rheumatoid factor 47.6% 61.5% 0.24c
Positive anti-CCP 30% 50.9% 0.30a
Positive antinuclear antibody 40% 33.7% 0.59d
Median C reactive protein (mg/L) 11.0
(IQR = 6.0–20.8)
10.7
(IQR  = 5.0–20.7)
0.85c
Median hemoglobin (g/dL) 13.5
(IQR = 12.0–14.0)
13.4
(IQR  = 12.4–14.0)
0.80c
Median prednisone dose (mg/day) 5.0
(IQR = 0.0–5.0)
5.0
(IQR  = 5.0–10.0)
0.03c
Metotrexate users 71.4% 73.9% 0.83d
Leﬂunomide users 42.8% 43.9% 0.92d
Antimalarial users 19.04% 21.9% 1.00a
Biologic medication users 9.5% 9.8% 1.00a
Median sedimentation rate 26.0
(IQR = 13.5–47.5)
39.0
(IQR  = 21.0–60.0)
0.12c
IQR, interquartile rate.
a Fisher test.
b Unpaired t test.
c Mann Whitney test.
d Chi squared test.
with certain immunological factors.12 In RA, circulating TNF-
is increased and there has been a suggestion that the level of
this cytokine may be connected to sleep disorders.12 Brain lev-
els of IL-1 and TNF are linked with sleep deprivation.12 One
study13 conducted in ten RA patients to assess whether anti
TNF drugs had any effect on the sleep pattern suggested that
its quality improved with this type of medication.
However, in the present study, when the elements that
are included in the DAS 28 were examined apart, the num-
ber of tender joint was the component responsible for the
association. Thus, pain and not inﬂammation could be the
real association. Sleep disturbance in patients with joint pain
has been noted not only in RA but in other chronic painful
conditions.14
The daily dose of prednisone was also related to lower
performance in the Pittsburg score in univariate analysis.
Endogenous glucocorticoids are critical for the pathogenesis
of sustained stress-related sleep disorders.15 High serum lev-
els of glucocorticoids induce poor sleep quality and shorter
sleep duration through receptors that are highly expressed in
the brain.16 Nevertheless, higher doses of prednisone are used
by patients with more  inﬂammation and it is possible that,
again, pain resulting from the inﬂammatory process could be
the true responsible for the relationship.
The Berlin apnea screening questionnaire displayed anPlease cite this article in press as: Goes AC, et al. Rheuma
http://dx.doi.org/10.1016/j.rbre.2016.07.011
independent association with poor sleep in RA. Drossaers-
Baker et al.17 showed that sleep apnea in their RA patients
was due to a mixed pattern: central and obstructive,suggesting that this problem is multifactorial. Contributors to
the obstructive component could be increased neck circum-
ference by glucocorticoid use, narrowing of upper airway by
changes in temporomandibular joint, reposition of cervical
axis in cases of cervical subluxation or even by diminished
muscle tone in the airway.17 A high BMI  is also common
in RA patients and was found in 60% of this sample. Verti-
cal luxation of the odontoid process may cause compression
of the brain stem and could result in central impairment
of breathing.18 Patients with hypoventilation complain of
headache upon awakening, nocturnal unrest, day-time sleepi-
ness and impaired concentration.19 These symptoms are often
mild and may be easily overlooked. Curiously, anti TNF drugs
are also described as improving the sleep apnea syndrome.19
In our sample the number of patients using this type of drug
was too small to allow any conclusions.
Finally, depression was independently linked to poor sleep
quality. Depression is a highly prevalent problem in RA1 and
contributes to disability, bad adherence to treatment, and poor
social functioning. Insomnia in depressed patients was ﬁrst
considered to be a symptom of depression.20 More  recently
there is evidence to sustain that there is a bidirectional
connection between these two variables. According to some
studies, sleep disorder is also a major risk factor for future
onset and for recurrence of depressive episodes.21,22toid arthritis and sleep quality. Rev Bras Reumatol. 2016.
Concluding, the present data show a high prevalence of
poor sleep in RA patients and that the main associated factors
are sleep apnea and depression.
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